- Consumer Products
- Latest 66.18
- Currency US$
- Change -0.74
- Percent Change -1.106 %
- Volume 1,204,660
- Thu Apr 24, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Dec 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jan 29||$-0.57||May 1||$-0.79|
12 months ended Apr 24, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)